CORT 118335 - Corcept Therapeutics

Drug Profile

CORT 118335 - Corcept Therapeutics

Alternative Names: CORT-118335

Latest Information Update: 24 Oct 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Corcept Therapeutics
  • Class Small molecules
  • Mechanism of Action Glucocorticoid receptor antagonists; Mineralocorticoid receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Metabolic disorders
  • Preclinical Non-alcoholic fatty liver disease

Most Recent Events

  • 15 Sep 2017 Phase-I clinical trials in Metabolic disorders (In volunteers) in United Kingdom (PO) (NCT03315338)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top